Varenicline Targets the Reinforcing-Enhancing Effect of Nicotine on Its Associated Salient Cue During Nicotine Self-administration in the Rat

Nicotine is acknowledged as the key addictive compound of tobacco. Varenicline (Champix® or Chantix®), mainly acting as a partial agonist at the α4β2 nicotinic receptor, is an approved smoking cessation pharmacotherapy, although with efficacy limited to a portion of smokers. Smokers differ in the mo...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Vernon Garcia-Rivas, Jean-François Fiancette, Nazzareno Cannella, Maria Carbo-Gas, Prisca Renault, Jessica Tostain, Véronique Deroche-Gamonet
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2019-07-01
Edice:	Frontiers in Behavioral Neuroscience
Témata:	intravenous self-administration nicotine cues individual differences varenicline rat
On-line přístup:	https://www.frontiersin.org/article/10.3389/fnbeh.2019.00159/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!